Target intelligence / Profile preview

Helicobacter pylori surface and cell wall components

Molecular classification
Bacterial cell wall, Bacterial outer membrane, Lipopolysaccharide, Peptidoglycan, Outer membrane protein
01

Overview

Helicobacter pylori surface and cell wall components comprise a diverse set of molecules, including peptidoglycan, lipopolysaccharides (LPS), and outer membrane proteins (OMPs), which are vital for the bacterium's survival in the gastric environment [1]. The peptidoglycan layer provides essential structural support and osmotic protection, making it a primary target for beta-lactam antibiotics like amoxicillin, which inhibit the cross-linking of peptidoglycan chains [2]. LPS on the surface often exhibits Lewis antigen mimicry, allowing the pathogen to evade the host's immune system by appearing as self and avoiding complement-mediated killing [4, 5]. Outer membrane proteins, such as BabA and SabA, function as adhesins that bind to gastric epithelial cells, facilitating persistent colonization and the delivery of virulence factors [3]. These surface components are also the focus of vaccine research, as they are the first points of contact with the host immune system and can induce protective antibody responses [1]. Disruption of these components or the inhibition of their synthesis leads to bacterial cell death or reduced virulence, which is the basis for current triple and quadruple therapy regimens [2]. Consequently, these structures are central to the management of H. pylori-related diseases, including chronic gastritis, peptic ulcers, and gastric adenocarcinoma [1].

Other names
H. pylori cell envelopeH. pylori outer membraneH. pylori surface antigensH. pylori cell wall
02

Mechanism of action

Inhibition of peptidoglycan synthesis by binding to penicillin-binding proteins (PBPs) and physical disruption of the bacterial cell membrane integrity.

03

Biological functions

Structural integrityAdhesionColonizationImmune evasionPathogenesis
04

Disease associations

GastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Antibiotic resistance (e.g., PBP mutations)Disruption of commensal gut microbiomeHypersensitivity and allergic reactions to beta-lactams
06

Interacting drugs

Amoxicillin

3 more in the full profile.

07

Biomarkers

H. pylori stool antigenUrea breath testAnti-H. pylori IgG antibodiesAnti-H. pylori IgA antibodies

Beyond the preview

Go deeper on Helicobacter pylori surface and cell wall components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori surface and cell wall components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call